Arcadia Biosciences, Inc. (NASDAQ:RKDA) Shares Shorted: Short Interest Down 48.8% in September

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 9,605 shares, a decrease of 48.8% from the August 31st total of 18,768 shares. Based on an average trading volume of 54,883 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.4% of the company’s stock are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Arcadia Biosciences in a report on Tuesday, September 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Read Our Latest Research Report on RKDA

Arcadia Biosciences Stock Up 1.4%

Shares of NASDAQ:RKDA traded up $0.00 during midday trading on Thursday, reaching $0.28. The company had a trading volume of 917,988 shares, compared to its average volume of 1,346,771. The business’s 50 day moving average price is $0.51 and its 200 day moving average price is $0.86. The stock has a market cap of $684,440.00, a PE ratio of -0.06 and a beta of 0.53. Arcadia Biosciences has a 1-year low of $0.22 and a 1-year high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) EPS for the quarter, missing the consensus estimate of ($0.56) by ($1.53). The company had revenue of $1.44 million for the quarter, compared to analyst estimates of $1.90 million. Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc is an agricultural biotechnology company focused on developing and commercializing plant-based products and crop technologies. The company has historically used advanced plant science and breeding techniques to improve the nutritional profile, sustainability, and commercial value of agricultural crops.

Its product portfolio has included GoodWheat, a wheat variety developed with reduced gluten and increased dietary fiber, and GoodHemp, a line of hemp products such as hemp seed, hemp protein, and hemp-derived ingredients.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.